Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.
Efficiency and specificity of viral vectors are vital issues in gene therapy. Insertion of peptide ligands into the adeno-associated viral (AAV) capsid at receptor binding sites can re-target AAV2-derived vectors to alternative cell types. Also, the use of serotypes AAV8 and -9 is more efficient tha...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3151269?pdf=render |
| _version_ | 1818279614833754112 |
|---|---|
| author | Stefan Michelfelder Karl Varadi Christina Raupp Agnes Hunger Jakob Körbelin Christiane Pahrmann Sonja Schrepfer Oliver J Müller Jürgen A Kleinschmidt Martin Trepel |
| author_facet | Stefan Michelfelder Karl Varadi Christina Raupp Agnes Hunger Jakob Körbelin Christiane Pahrmann Sonja Schrepfer Oliver J Müller Jürgen A Kleinschmidt Martin Trepel |
| author_sort | Stefan Michelfelder |
| collection | DOAJ |
| description | Efficiency and specificity of viral vectors are vital issues in gene therapy. Insertion of peptide ligands into the adeno-associated viral (AAV) capsid at receptor binding sites can re-target AAV2-derived vectors to alternative cell types. Also, the use of serotypes AAV8 and -9 is more efficient than AAV2 for gene transfer to certain tissues in vivo. Consequently, re-targeting of these serotypes by ligand insertion could be a promising approach but has not been explored so far. Here, we generated AAV8 and -9 vectors displaying peptides in the threefold spike capsid domain. These peptides had been selected from peptide libraries displayed on capsids of AAV serotype 2 to optimize systemic gene delivery to murine lung tissue and to breast cancer tissue in PymT transgenic mice (PymT). Such peptide insertions at position 590 of the AAV8 capsid and position 589 of the AAV9 capsid changed the transduction properties of both serotypes. However, both peptides inserted in AAV8 did not result in the same changes of tissue tropism as they did in AAV2. While the AAV2 peptides selected on murine lung tissue did not alter tropism of serotypes 8 and -9, insertion of the AAV2-derived peptide selected on breast cancer tissue augmented tumor gene delivery in both serotypes. Further, this peptide mediated a strong but unspecific in vivo gene transfer for AAV8 and abrogated transduction of various control tissues for AAV9. Our findings indicate that peptide insertion into defined sites of AAV8 and -9 capsids can change and improve their efficiency and specificity compared to their wild type variants and to AAV2, making these insertion sites attractive for the generation of novel targeted vectors in these serotypes. |
| first_indexed | 2024-12-12T23:36:08Z |
| format | Article |
| id | doaj.art-3bd592ed36f74930963879b03008941e |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-12T23:36:08Z |
| publishDate | 2011-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-3bd592ed36f74930963879b03008941e2022-12-22T00:07:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0168e2310110.1371/journal.pone.0023101Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.Stefan MichelfelderKarl VaradiChristina RauppAgnes HungerJakob KörbelinChristiane PahrmannSonja SchrepferOliver J MüllerJürgen A KleinschmidtMartin TrepelEfficiency and specificity of viral vectors are vital issues in gene therapy. Insertion of peptide ligands into the adeno-associated viral (AAV) capsid at receptor binding sites can re-target AAV2-derived vectors to alternative cell types. Also, the use of serotypes AAV8 and -9 is more efficient than AAV2 for gene transfer to certain tissues in vivo. Consequently, re-targeting of these serotypes by ligand insertion could be a promising approach but has not been explored so far. Here, we generated AAV8 and -9 vectors displaying peptides in the threefold spike capsid domain. These peptides had been selected from peptide libraries displayed on capsids of AAV serotype 2 to optimize systemic gene delivery to murine lung tissue and to breast cancer tissue in PymT transgenic mice (PymT). Such peptide insertions at position 590 of the AAV8 capsid and position 589 of the AAV9 capsid changed the transduction properties of both serotypes. However, both peptides inserted in AAV8 did not result in the same changes of tissue tropism as they did in AAV2. While the AAV2 peptides selected on murine lung tissue did not alter tropism of serotypes 8 and -9, insertion of the AAV2-derived peptide selected on breast cancer tissue augmented tumor gene delivery in both serotypes. Further, this peptide mediated a strong but unspecific in vivo gene transfer for AAV8 and abrogated transduction of various control tissues for AAV9. Our findings indicate that peptide insertion into defined sites of AAV8 and -9 capsids can change and improve their efficiency and specificity compared to their wild type variants and to AAV2, making these insertion sites attractive for the generation of novel targeted vectors in these serotypes.http://europepmc.org/articles/PMC3151269?pdf=render |
| spellingShingle | Stefan Michelfelder Karl Varadi Christina Raupp Agnes Hunger Jakob Körbelin Christiane Pahrmann Sonja Schrepfer Oliver J Müller Jürgen A Kleinschmidt Martin Trepel Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo. PLoS ONE |
| title | Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo. |
| title_full | Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo. |
| title_fullStr | Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo. |
| title_full_unstemmed | Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo. |
| title_short | Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo. |
| title_sort | peptide ligands incorporated into the threefold spike capsid domain to re direct gene transduction of aav8 and aav9 in vivo |
| url | http://europepmc.org/articles/PMC3151269?pdf=render |
| work_keys_str_mv | AT stefanmichelfelder peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo AT karlvaradi peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo AT christinaraupp peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo AT agneshunger peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo AT jakobkorbelin peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo AT christianepahrmann peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo AT sonjaschrepfer peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo AT oliverjmuller peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo AT jurgenakleinschmidt peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo AT martintrepel peptideligandsincorporatedintothethreefoldspikecapsiddomaintoredirectgenetransductionofaav8andaav9invivo |